Patient reported exposure to smoking and alcohol abuse are associated with pain and other complications in patients with chronic pancreatitis.


Journal

Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]
ISSN: 1424-3911
Titre abrégé: Pancreatology
Pays: Switzerland
ID NLM: 100966936

Informations de publication

Date de publication:
Jul 2020
Historique:
received: 12 12 2019
revised: 25 03 2020
accepted: 01 05 2020
pubmed: 9 6 2020
medline: 10 7 2021
entrez: 9 6 2020
Statut: ppublish

Résumé

Smoking and alcohol abuse are established risk factors for chronic pancreatitis (CP). Few studies have examined how exposure to smoking and alcohol abuse act as risk factors for complications in CP. Our aim was to examine associations between patient reported exposure to smoking and alcohol abuse and complications in CP in a large cohort of patients from the Scandinavian and Baltic countries. We retrieved data on demographics, CP related complications and patients' histories of exposure to smoking and alcohol abuse from the Scandinavian Baltic Pancreatic Club database. Associations were investigated by univariate and multivariate logistic regression analyses. Results are presented as odds ratios (OR) with 95% confidence intervals. A complete history of smoking and alcohol exposure was available for 932 patients. In multivariate regression analyses, the presence of pain and exocrine pancreatic insufficiency were both significantly associated with history of smoking (OR 1.94 (1.40-2.68), p < 0.001 and OR 1.89 (1.36-2.62), p < 0.001, respectively) and alcohol abuse (OR 1.66 (1.21-2.26), p = 0.001 and 1.55 (1.14-2.11), p = 0.005, respectively). Smoking was associated with calcifications (OR 2.89 (2.09-3.96), p < 0.001), moderate to severe ductal changes (OR 1.42 (1.05-1.92), p = 0.02), and underweight (OR 4.73 (2.23-10.02), p < 0.001). History of alcohol abuse was associated with pseudocysts (OR 1.38 (1.00-1.90) p = 0.05) and diabetes mellitus (OR 1.44 (1.03-2.01), p = 0.03). There were significantly increased odds-ratios for several complications with increasing exposure to smoking and alcohol abuse. Smoking and alcohol abuse are both independently associated with development of complications in patients with CP. There seems to be a dose-dependent relationship between smoking and alcohol abuse and complications in CP.

Sections du résumé

BACKGROUND/OBJECTIVES OBJECTIVE
Smoking and alcohol abuse are established risk factors for chronic pancreatitis (CP). Few studies have examined how exposure to smoking and alcohol abuse act as risk factors for complications in CP. Our aim was to examine associations between patient reported exposure to smoking and alcohol abuse and complications in CP in a large cohort of patients from the Scandinavian and Baltic countries.
METHODS METHODS
We retrieved data on demographics, CP related complications and patients' histories of exposure to smoking and alcohol abuse from the Scandinavian Baltic Pancreatic Club database. Associations were investigated by univariate and multivariate logistic regression analyses. Results are presented as odds ratios (OR) with 95% confidence intervals.
RESULTS RESULTS
A complete history of smoking and alcohol exposure was available for 932 patients. In multivariate regression analyses, the presence of pain and exocrine pancreatic insufficiency were both significantly associated with history of smoking (OR 1.94 (1.40-2.68), p < 0.001 and OR 1.89 (1.36-2.62), p < 0.001, respectively) and alcohol abuse (OR 1.66 (1.21-2.26), p = 0.001 and 1.55 (1.14-2.11), p = 0.005, respectively). Smoking was associated with calcifications (OR 2.89 (2.09-3.96), p < 0.001), moderate to severe ductal changes (OR 1.42 (1.05-1.92), p = 0.02), and underweight (OR 4.73 (2.23-10.02), p < 0.001). History of alcohol abuse was associated with pseudocysts (OR 1.38 (1.00-1.90) p = 0.05) and diabetes mellitus (OR 1.44 (1.03-2.01), p = 0.03). There were significantly increased odds-ratios for several complications with increasing exposure to smoking and alcohol abuse.
CONCLUSION CONCLUSIONS
Smoking and alcohol abuse are both independently associated with development of complications in patients with CP. There seems to be a dose-dependent relationship between smoking and alcohol abuse and complications in CP.

Identifiants

pubmed: 32507681
pii: S1424-3903(20)30152-6
doi: 10.1016/j.pan.2020.05.001
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

844-851

Informations de copyright

Copyright © 2020 IAP and EPC. Published by Elsevier B.V. All rights reserved.

Auteurs

Erling Tjora (E)

Pediatric Department, Haukeland University Hospital, Bergen, Norway; Center for Diabetes Research, University of Bergen, Bergen, Norway. Electronic address: erling.tjora@helse-bergen.no.

Georg Dimcevski (G)

Department of Clinical Medicine, University of Bergen, Bergen, Norway.

Stephan L Haas (SL)

Centre for Digestive Diseases, Karolinska University Hospital, Stockholm, Sweden.

Friedemann Erchinger (F)

Department of Clinical Medicine, University of Bergen, Bergen, Norway.

Miroslav Vujasinovic (M)

Centre for Digestive Diseases, Karolinska University Hospital, Stockholm, Sweden.

Matthias Löhr (M)

Centre for Digestive Diseases, Karolinska University Hospital, Stockholm, Sweden.

Camilla Nøjgaard (C)

Department of Gastroenterology, Hvidovre University Hospital, Copenhagen, Denmark.

Srdan Novovic (S)

Department of Gastroenterology, Hvidovre University Hospital, Copenhagen, Denmark.

Imanta Ozola Zalite (IO)

Center of Gastroenterology, Hepatology and Nutrition, Pauls Stradins Clinical University Hospital, Riga, Latvia.

Aldis Pukitis (A)

Center of Gastroenterology, Hepatology and Nutrition, Pauls Stradins Clinical University Hospital, Riga, Latvia.

Truls Hauge (T)

Department of Gastroenterology, Oslo University Hospital, Oslo, Norway; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.

Anne Waage (A)

Department of Hepato-Pancreato-Biliary Surgery, Oslo University Hospital, Oslo, Norway.

Stine Roug (S)

Digestive Disease Center, Bispebjerg Hospital, Copenhagen, Denmark.

Evangelos Kalaitzakis (E)

Copenhagen University Hospital/Herlev, University of Copenhagen, Copenhagen, Denmark.

Björn Lindkvist (B)

Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.

Søren Schou Olesen (SS)

Center for Pancreatic Diseases, Department of Gastroenterology and Hepatology, Aalborg University Hospital, Aalborg, Denmark.

Trond Engjom (T)

Department of Clinical Medicine, University of Bergen, Bergen, Norway; Medical Department, Haukeland University Hospital, Bergen, Norway.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH